The International Journal of Biochemistry & Cell Biology
Cells in focusCancer stem cells
Introduction
Stem cells are characterized by the capacity for self-renewal and the ability to differentiate into diverse specialized cell types. This concept has been extended from the embryonic stem cells (ESCs) and adult stem cells to cancer stem cells (CSCs) and induced pluripotent stem (IPS) cells. Through self-renewal, more stem cells are generated which maintain an undifferentiated status. Through differentiation, stem cells give rise to a mature cell type. Embryonic stem cells are capable of differentiating into all tissues during embryonic development. Adult stem cells play important roles in replenishing and repairing adult tissues (Lawson et al., 2009). Researchers have successfully reprogrammed somatic cells into stem-like cells – known as induced pluripotent stem cells (iPSCs) – which share many of the characteristics of ESCs (Takahashi and Yamanaka, 2006). Emerging evidence has indicated a subpopulation of stem-like cells within tumors, known as CSCs, which exhibit characteristics of both stem cells and cancer cells. In addition to self-renewal and differentiation capacities, CSCs have the ability to seed tumors when transplanted into an animal host. CSCs can be distinguished from other cells within the tumor by symmetry of their cell division and alterations in their gene expression (Rosen and Jordan, 2009).
microRNAs (miRNAs) are a class of non-coding small RNAs that are single-stranded with ∼20 nt in length. miRNAs regulate the stability or translational efficiency of targeted messenger RNAs through complementary interaction with the 3′ untranslated region of target genes. Over 1000 mammalian miRNAs have been identified or predicted from mammals. It is predicted that one miRNA can target hundreds of genes. The expression of about one-third of human genes is regulated by multiple miRNAs. miRNAs have been demonstrated to regulate a broad range of biological processes including embryonic development, cell cycle, cell proliferation, tumor initiation and progression, cancer metastasis, self-renewal, and differentiation of stem cells (Yu et al., 2010a).
The role for miRNA in regulating stem cells was implicit in the original discovery of miRNA. The first two miRNAs discovered, lin-4 and let-7, are involved in regulating the timing of larval to adult cell fates in Caenorhabditis elegans (Lee et al., 1993, Reinhart et al., 2000). Expression of lin-4 and let-7 was undetectable in the early embryo, increased at late larval stage, and was highly expressed in the adult stage – indicating a potential role in promoting embryonic cell differentiation. Since the identification of miRNAs that were exclusively expressed in ES cells by the Sharp Laboratory (Houbaviy et al., 2003), a role for specific miRNA in stem cell iPSCs and CSCs, has been described. miRNAs are differentially expressed in ES cells (Houbaviy et al., 2003). Key ES cell transcription factors are associated with promotors for miRNAs that are preferentially expressed in ES cells (Marson et al., 2008). Analysis of miRNA in human breast CSCs (hBCSCs) demonstrated concordant regulation of a subset of miRNA in hBCSCs and embryonal carcinoma cells (Shimono et al., 2009). Subsequent studies revealed both similarities, but also distinguishable differences in the miRNA expression profiles of human iPSCs and human ESCs. Interestingly, these studies identify important differences between pluripotent cells and cancer cells. Collectively, these studies suggest both similarities and differences between subsets of stem cell states and cancer with emerging patterns, which are discussed further in Section 3.
Section snippets
Cancer stem cells
The first modern evidence for a role of stem cells in cancer came in 1994 with a study of human acute myeloid leukemia (Lapidot et al., 1994), in which an AML-initiating cell population was identified from AML patients by transplantation into severe combined immune-deficient (SCID) mice. The leukemia-initiating cells were enriched on the basis of cell surface marker expression (CD34+/CD38−). In 2003, human CSCs were identified in solid tumors, including breast (Al-Hajj et al., 2003) and brain
Signaling pathways and miRNA regulation of stem cells
CSC self-renewal and differentiation are tightly controlled by multiple regulatory networks, including cytokines from the cancer cell microenvironment. The function of several signaling pathways control cancer progression, including the hedgehog, Notch, and Wnt/β-catenin pathway has been previously reviewed (Reya and Clevers, 2005, DeSano and Xu, 2009). However, herein we review the relationship of these pathways to cellular polarity and cell division symmetry (Fig. 1A–E).
Wnt signaling plays an
Clinical relevance
CSCs are a novel cancer target. Hoey et al. (2009) developed antibodies against delta like 4 ligand (DLL4), a component of Notch signaling pathway. In a mouse model of human colon cancer, anti-DLL4 inhibited the expression of Notch target genes and reduced proliferation of tumor cells. Furthermore, anti-DLL4, either alone or in combination with the chemotherapeutic agent irinotecan, reduced CSC function. Jin et al. (2009) applied a monoclonal antibody 7G3, to the IL-3 receptor alpha chain
Acknowledgments
This work was supported in part by grants R01CA070896, R01CA075503, R01CA132115, R01CA107382, R01CA086072 and P30CA056036 from NIH; grants from The Breast Cancer Research Foundation and the Dr. Ralph and Marian C. Faulk Medical Research Trust (R.G.P.); a grant from Pennsylvania Department of Health (R.G.P.) and grants 2012CB966800 from National Basic Research Program of China and 81172515 from Natural Science Foundation of China (to Yu, Z.). There are no conflicts of interest associated with
References (54)
- et al.
Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence
Cancer Cell
(2008) - et al.
Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures
Cell Stem Cell
(2009) Wnt/beta-catenin signaling in development and disease
Cell
(2006)- et al.
ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome
Cell Stem Cell
(2007) - et al.
DLL4 blockade inhibits tumor growth and reduces tumor-initiating cell frequency
Cell Stem Cell
(2009) - et al.
Embryonic stem cell-specific microRNAs
Developmental Cell
(2003) - et al.
Monoclonal antibody-mediated targeting of CD123, IL-3 receptor alpha chain, eliminates human acute myeloid leukemic stem cells
Cell Stem Cell
(2009) - et al.
Wnt7a activates the planar cell polarity pathway to drive the symmetric expansion of satellite stem cells
Cell Stem Cell
(2009) - et al.
The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14
Cell
(1993) - et al.
The epithelial–mesenchymal transition generates cells with properties of stem cells
Cell
(2008)
Wnt signaling promotes reprogramming of somatic cells to pluripotency
Cell Stem Cell
MicroRNA gene regulatory pathways in the establishment and maintenance of ESC identity
Cell Stem Cell
MicroRNA profiling reveals two distinct p53-related human pluripotent stem cell states
Cell Stem Cell
MicroRNA expression profile of bronchioalveolar stem cells from mouse lung
Biochemical and Biophysical Research Communications
Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells
Cell
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors
Cell
Cell fate determination factor Dachshund reprograms breast cancer stem cell function
Journal of Biological Chemistry
Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis
Cell
let-7 regulates self renewal and tumorigenicity of breast cancer cells
Cell
microRNA, cell cycle, and human breast cancer
American Journal of Pathology
Secreted monocytic miR-150 enhances targeted endothelial cell migration
Molecular Cell
Ablation of breast cancer stem cells with radiation
Translational Oncology
Prospective identification of tumorigenic breast cancer cells
Proceedings of the National Academy of Sciences of the United States of America
Oct4/Sox2-regulated miR-302 targets cyclin D1 in human embryonic stem cells
Molecular and Cellular Biology
Epithelial–mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells
Journal of Clinical Investigation
Notch signaling in stem cell systems
Stem Cells
MicroRNA regulation of cancer stem cells and therapeutic implications
AAPS Journal
Cited by (497)
The impact of endocrine-disrupting chemicals on stem cells: Mechanisms and implications for human health
2025, Journal of Environmental Sciences (China)miR-29a-KLF4 signaling inhibits breast tumor initiation by regulating cancer stem cells
2024, International ImmunopharmacologyCD95 promotes stemness of colorectal cancer cells by lncRNA MALAT1
2024, Life SciencesDrug repurposing: A novel strategy to target cancer stem cells and therapeutic resistance
2024, Genes and DiseasesCancer cell cycle heterogeneity as a critical determinant of therapeutic resistance
2024, Genes and Diseases